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Abstract 
Background: Equine gastric ulcer syndrome (EGUS) is common in adult horses, particularly those involved in perfor‑
mance disciplines. Currently, detection of EGUS by gastroscopy is the only reliable ante mortem method for definitive 
diagnosis; however it is unsuitable as a screening test because it is expensive, time consuming, and is not readily avail‑
able to most veterinarians. Sucrose permeability testing represents a simple, economical alternative to gastroscopy 
for screening purposes, and the feasibility of this approach in the horse has been previously reported. The aim of this 
study was to determine the diagnostic accuracy of blood sucrose as a screening test for EGUS in a large group of adult 
horses with and without naturally occurring gastric disease.
Results: One hundred and one adult horses with or without naturally occurring gastric ulceration were studied. The 
diagnostic accuracy of blood sucrose for diagnosis of gastric lesions (GL), glandular lesions (GDL), squamous lesions 
(SQL), and clinically significant lesions (CSL) at 45 and 90 min after administration of 1 g/kg of sucrose via nasogastric 
intubation was assessed using receiver operator characteristics (ROC) curves and calculating the area under the curve 
(AUC). For each lesion type, sucrose concentration in blood was compared to gastroscopy, as the gold standard, and 
sensitivities (Se) and specificities (Sp) were calculated across a range of sucrose concentrations. Ulcer grading was 
performed blindly by one observer; and the results were validated by comparing them with that of two other observ‑
ers, and calculating the level of agreement. Cut‑off values were selected manually to optimize Se. The prevalence of 
GL, GDL, SQL, and CSL was 83, 70, 53 and 58% respectively. At the selected cut‑offs, Se ranged from 51 to 79% and Sp 
ranged from 43 to 72%, depending upon the lesion type and time of sampling.
Conclusions: Blood sucrose is neither a sensitive or specific test for detecting EGUS in this population of adult horses 
with naturally occurring gastric ulceration. Further studies aimed at evaluating the performance characteristics of the 
test in different study populations are warranted. Given the limitations of endoscopy, due consideration should also 
be given to alternative methods for comparison of blood sucrose with a gold standard.
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Background
Equine gastric ulcer syndrome (EGUS) is a term used 
to describe erosive and ulcerative diseases of the equine 
stomach; and can be further classified into equine squa-
mous gastric disease (ESGD) and equine glandular gas-
tric disease (EGGD) based on the anatomical region 
affected [1]. EGUS is common in horses and although the 
clinical ramifications of this disease have as yet, not been 
completely elucidated, it remains an important disease 
in the equine industry. Performance horses are particu-
larly susceptible, with 47–100% of Thoroughbred race-
horses [2–5], 44–87% of Standardbred racehorses [6–8], 
33–93% of endurance horses [9, 10] and 58–64% of show 
and sport horses [11, 12] found to have gastric lesions on 
gastroscopy. Non-performance horses are also suscepti-
ble to EGUS, with ulcers found in the gastric mucosa of 
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11–67% of sedentary horses and horses that partake in 
less strenuous activities [13–15].
Currently, detection of EGUS by gastroscopy is the only 
reliable ante mortem method for definitive diagnosis in 
horses [16] and is considered the gold standard against 
which all other diagnostic tests are compared [1]. Disad-
vantages of gastroscopy are that it’s not readily available 
to most veterinarians, it is an inefficient expenditure of 
time, and it requires a minimum level of expertise to per-
form and interpret. Furthermore, gastroscopy is costly 
to the client and with an increase in public awareness of 
EGUS and its popularity as a ‘catch-all’ diagnosis for poor 
performance in sport horses, many owners are electing to 
treat their horses on an empirical basis without the ben-
efit of a definite diagnosis. Given the current economic 
climate and the rising costs of omeprazole, it is easy then 
to imagine that owners and veterinarians would be inter-
ested in using an economical screening test to rule out 
gastric ulcers. Such a screening test should ideally have 
a high sensitivity as it will correctly identify most horses 
with gastric ulcers, remembering that many horses with 
EGUS will not demonstrate clinical signs, and are consid-
ered to have ‘silent’ or non-clinical gastric ulceration [14, 
17–20].
Sucrose permeability testing represents a simple, eco-
nomical alternative to gastroscopy for screening pur-
poses, and the feasibility of this approach in the horse 
has been previously reported [21–23]. Because of its 
large molecular size (342 Da), sucrose is not able to per-
meate across healthy gastrointestinal mucosa, but it has 
been reported to cross the mucosa in the presence of 
gastrointestinal disease, presumably due to an changes in 
intestinal tight junction permeability or directly through 
gaps in the epithelium caused by erosion or ulceration 
[24–26]. The efficiency of the mucosal disaccharidases 
and the monosaccharide transport systems in the equine 
small intestine has been established by a series of oral 
disaccharide and monosaccharide tolerance tests, and it 
has been demonstrated that adult horses are fully capa-
ble of rapidly hydrolyzing sucrose [27, 28]. Furthermore, 
sucrase has the highest activity in the duodenum of the 
horse, with concentrations similar to those reported in 
the intestine of other non-ruminant species [29]. If pre-
sent in blood, sucrose is cleared via the urine; it is not 
metabolized and the body does not produce it [30, 31]. 
Therefore, increased amounts of sucrose in blood after 
an oral dose is site specific for increased gastric perme-
ability, and can be used to predict the presence of gastric 
disease [32–38].
The objective of this study was to determine the diag-
nostic accuracy of blood sucrose as a potential screening 
test for EGUS in adult horses by comparing it to gastros-
copy as the gold standard.
Methods
Study design
The study was conducted as a blind comparison to a gold 
standard.
Study population
One hundred and one adult horses were eligible for inclu-
sion in the study and were recruited from horses that had 
been referred to the University of Helsinki Equine Teach-
ing Hospital, Finland for gastroscopy and from a local 
riding center. The horses were used for a wide range of 
equestrian activities, ranging from dressage to racing, 
and were recruited on the assumption that up to 53% of 
them would be affected by naturally occurring gastric 
ulceration of EGUS severity score  ≥2 [14, 16]. Horses 
were excluded from the study if they had received non-
steroidal anti-inflammatory drugs or omeprazole within 
7 days prior to testing. This was done to avoid confound-
ing changes in gastric permeability secondary to admin-
istration of these drugs [23, 39, 40].
Gastroscopy
Owners were asked to withhold food from their horses for 
16 h and water for 6 h prior to sucrose testing. Following 
completion of fasting, blood samples (10  ml) were col-
lected in vacuumed clot tubes from the jugular vein; horses 
were sedated with a combination of intravenous detomi-
dine hydrochloride (10  µg/kg body weight (BW)1 and 
butorphanol (0.025 mg/kg BW)2; and gastroscopy was per-
formed using a previously described technique [21].
All endoscopic examinations were recorded and 
archived. For each horse, video recordings and still-frame 
images were taken of the stomach from the right side of 
the stomach along the margo plicatus, the dorsal part of 
the fundus, the greater curvature along the margo pli-
catus, the lesser curvature along the margo plicatus, the 
glandular mucosa in the region of the pylorus and the 
proximal duodenum [41].
Administration of sucrose and collection of samples
Immediately following gastroscopy, 1  g/kg BW of 
sucrose3 was administered as a 10% solution via nasogas-
tric tube to each horse. Blood samples (10 ml) were then 
collected in vacuumed clot tubes from the jugular vein at 
45 and 90 min after administration of sucrose. These time 
points were chosen based upon data from a previous 
study which indicated that peak sucrose concentrations 
occur approximately between 45 and 90 min after sucrose 
1 Domosedan, Elanco Animal Health, UK.
2 Butador, Chanelle Vet animal health, UK.
3 Kidesokeri 530, Sucros Oy, Finland.
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administration [21]. Horses were not given access to food 
until the final blood sample had been collected to prevent 
ingestion of sucrose that may have been present in the 
food. Following blood collection, the serum was sepa-
rated by centrifugation (10  min at 2000×g) and then 
stored in a freezer at −80 °C until analysis.
Lesion assessment
Following completion of data collection, video recordings 
and still-frame images from each horse were reviewed 
independently by a board-certified internist (BS) who 
was blinded to the results of the sucrose assay. For each 
set of videos/images, the observer was asked to answer 
a set of dichotomous (yes or no) questions: does the 
horse have (1) gastric lesions? (2) glandular lesions? (3) 
squamous lesions? and (4) are the gastric lesions clini-
cally significant? The term “gastric lesion” was used to 
describe lesions throughout the gastric mucosa and is 
synonymous with the term EGUS. In contrast, the terms 
“glandular lesion” and “squamous lesion” were used to 
differentiate the two different anatomical regions of 
the equine stomach and are synonymous with the term 
EGGD and ESGD respectively [1]. Clinically significant 
gastric lesions were used as a proxy indicator of ulcer 
severity and were defined as lesions that the observer 
would consider severe enough to warrant treatment. The 
term ‘lesion’ rather than ‘ulceration’ was used to enable 
the observer to report on the presence of other types of 
lesions (e.g. erosions) in addition to ulceration, as any 
damage to the mucosa of the stomach has the theoretical 
potential to increase permeability to sucrose [24–26].
Inter‑observer agreement
In order to assess the validity of the gastroscopy assess-
ment, the observations for each horse were compared with 
observations made by two other board certified internists 
on the same set of video recordings and still-frame images 
(GH, MH), and the level of agreement was calculated.
Sample processing and analyses
Serum was analyzed for sucrose using a previously vali-
dated gas chromatography-flame ionization detection 
(GC-FID) assay for quantifying sucrose in equine serum 
[42].
Statistical analysis
The overall diagnostic accuracy of blood sucrose for 
diagnosis of GL, GDL, SQL and CSL was assessed using 
receiver operator characteristics (ROC) curves and cal-
culating the area under the curve (AUC). For each diag-
nostic criterion, sucrose concentration in blood at 45 
and 90 min was compared with gastroscopy as the gold 
standard; and sensitivities (Se), specificities (Sp), positive 
predictive values (PPV) and negative predictive values 
(NPV) were calculated across a range of sucrose con-
centrations. Optimal cut-off values were then selected 
manually to optimize sensitivity and provide a practical 
threshold for practitioners in the field when screening 
horses for EGUS. Confidence intervals were set at 95% 
(95% CI).
Inter-observer agreement was summarized as the per-
centage of perfect (100%) agreements between observers 
for each diagnostic criterion, and a kappa coefficient (K) 
was calculated.




One hundred and one adult horses were accepted into 
the study; 59 mares, 4 stallions, and 38 geldings. Horses 
ranged from two to 22  years of age (median, 9.9  years). 
Body weight ranged from 400 to 683 kg (median, 518 kg). 
Breeds included 37/101 Warmbloods, 25/101 Finnhorses, 
34/101 Standardbreds, 3/101 Welsh Ponies, 1/101 Tra-
khener, and 1/101 Arab. Horses were used for a variety 
of purposes, including eventing, show jumping, dressage, 
trotting and general riding purposes. Fifty-three horses 
were demonstrating clinical signs suggestive of EGUS at 
the time of gastroscopy.
Gastroscopy
The overall prevalence of gastric lesions (ulcers or ero-
sions) was 83%. Lesions were most common in the glan-
dular mucosae (70%), followed by the squamous mucosae 
(53%). Fifty eight percent of the horses had gastric lesions 
that were severe enough to be considered clinically sig-
nificant i.e. requiring treatment. Squamous lesions were 
most frequently observed in the region of the cardia and 
along the lesser curvature of the stomach adjacent to the 
margo plicatus; and consisted primarily of small single 
ulcers characteristic of EGUS severity score ≤2. Glandu-
lar lesions were exclusively observed around the pylorus 
and consisted primarily of focal raised hemorrhagic or 
fibrinous lesions.
Sucrose permeability
All horses tolerated sucrose permeability testing and no 
adverse effects were noted following administration of 
the sucrose solution. On analysis of the serum samples, 
all horses demonstrated an increase in serum sucrose 
concentration over time, with peak serum sucrose con-
centrations occurring 90 min after administration of the 
sucrose solution.
4 R Foundation for Statistical Computing, Vienna, Austria.
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The mean  ±  SD serum sucrose concentration at 
45  min was 6.85  ±  4.90  µmol/l for normal horses 
(n = 17); 9.66 ± 9.16 µmol/l for horses with GL (n = 84); 
9.44  ±  9.27  µmol/l for horses with GDL (n  =  71); 
10.56 ±  8.66  µmol/l for horses with SQL (n =  54); and 
10.43 ±  9.22  µmol/l for horses with CSL (n =  59). The 
mean  ±  SD serum sucrose concentration at 90  min 
was 7.22  ±  4.65  µmol/l for normal horses (n  =  17); 
10.29  ±  8.12  µmol/l for horses with GL (n  =  84); 
9.86  ±  7.54  µmol/l for horses with GDL (n  =  71); 
11.53 ±  8.17  µmol/l for horses with SQL (n =  54); and 
11.24 ± 8.55 µmol/l for horses with CSL (n = 59).
Diagnostic accuracy of blood sucrose for diagnosis of EGUS
ROC curves for each diagnostic criterion at 45 and 
90  min after sucrose administration are illustrated in 
Figs. 1 and 2.
Gastric lesions
The AUC  ±  95% CI for blood sucrose concentration 
when used to distinguish between normal horses and 
horses with GL at 45 and 90  min was 0.59 (0.44–0.74) 
and 0.62 (0.47–0.76) respectively. Sucrose concentra-
tions of 4.61 µmol/l at 45 min and 4.57 µmol/l at 90 min 
were selected as the optimal cut-offs for discriminating 
between normal horses and horses with GL. The Se, Sp, 
PPV and NPV of blood sucrose at 45 and 90 min for diag-
nosis of GL using the selected cut-off values are depicted 
in Table 1.
Glandular lesions
The AUC  ±  95% CI for blood sucrose concentration 
when used to distinguish between normal horses and 
horses with GDL at 45 and 90 min was 0.51 (0.39–0.64) 
and 0.53 (0.40–0.66) respectively. Sucrose concentra-
tions of 5.80 µmol/l at 45 min and 6.05 µmol/l at 90 min 
were selected as the optimal cut-offs for discriminating 
between normal horses and horses with GDL. The Se, 
Sp, PPV and NPV of blood sucrose at 45 and 90 min for 
diagnosis of GDL using the selected cut-off values are 
depicted in Table 2.
Squamous lesions
The AUC for blood sucrose concentration when used 
to distinguish between normal horses and horses with 
SQL at 45 and 90  min was 0.65 (0.55–0.76) and 0.68 
(0.58–0.79) respectively. Sucrose concentrations of 
7.86  µmol/l at 45  min and 8.24  µmol/l at 90  min were 
selected as the optimal cut-offs for discriminating 
between normal horses and horses with SQL. The Se, 
Sp, PPV and NPV of blood sucrose at 45 and 90 min for 
diagnosis of SQL using the selected cut-off values are 
depicted in Table 3.
Clinically significant gastric lesions
The AUC for blood sucrose concentration when used to 
distinguish between normal horses and horses with CSL 
Fig. 1 ROC curves for blood sucrose concentration when used to 
distinguish between normal horses and horses with GL, GDL, SQL and 
CSL at 45 min after administration of 1 g/kg of sucrose via nasogastric 
intubation. AUC area under the curve
Fig. 2 ROC curves for blood sucrose concentration when used to 
distinguish between normal horses and horses with GL, GDL, SQL and 
CSL at 90 min after administration of 1 g/kg of sucrose via nasogastric 
intubation. AUC area under the curve
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at 45 and 90  min was 0.63 (0.52–0.74) and 0.66 (0.55–
0.77) respectively. Sucrose concentrations of 4.61 µmol/l 
at 45  min and 5.87  µmol/l at 90  min were selected as 
the optimal cut-offs for discriminating between normal 
horses and horses with clinically significant lesions. The 
Se, Sp, PPV and NPV of blood sucrose at 45 and 90 min 
for diagnosis of CSL using the selected cut-off values are 
depicted in Table 4.
Inter‑observer agreement
When asked to answer if each horse has (1) gastric 
lesions; (2) glandular lesions; (3) squamous lesions; and 
Table 1 Sensitivity, specificity, positive and  negative predictive values of  blood sucrose for  diagnosis of  GL in  horses 
after administration of 1 g/kg of sucrose via nasogastric intubation
GL gastric lesions, Se sensitivity, Sp specificity, NPV negative predictive value, PPV positive predictive value, 95% CI 95% confidence intervals
Time of sampling (min) Cut‑off (µmol/l) Disease present Disease absent Sp (%) Se (%) NPV (%) PPV (%)
95% CI 95% CI 95% CI 95% CI
45 4.61 84 17 52.9 67.9 25.0 87.7
28–77 57–78 12–42 77–95
90 4.57 84 17 47.1 78.6 30.8 88.0
23–72 68–87 14–52 78–94
Table 2 Sensitivity, specificity, positive and  negative predictive values of  blood sucrose for  diagnosis of  GDL in  horses 
after administration of 1 g/kg of sucrose via nasogastric intubation
GL gastric lesions, Se sensitivity, Sp specificity, NPV negative predictive value, PPV positive predictive value, 95% CI 95% confidence intervals
Time of sampling (min) Cut‑off (µmol/l) Disease present Disease absent Sp (%) Se (%) NPV (%) PPV (%)
95% CI 95% CI 95% CI 95% CI
45 5.80 71 31 48.1 50.7 30.0 69.2
30–67 39–63 18–45 55–81
90 6.05 71 31 43.3 66.2 35.1 73.4
26–63 54–77 20–53 61–84
Table 3 Sensitivity, specificity, positive and  negative predictive values of  blood sucrose for  diagnosis of  SQL in  horses 
after administration of 1 g/kg of sucrose via nasogastric intubation
SQL squamous lesions, Se sensitivity, Sp specificity, NPV negative predictive value, PPV positive predictive value, 95% CI 95% confidence intervals
Time of sampling (min) Cut‑off (µmol/l) Disease present Disease absent Sp (%) Se (%) NPV (%) PPV (%)
95% CI 95% CI 95% CI 95% CI
45 7.86 54 47 68.1 50.0 54.2 64.3
53–81 36–64 41–67 48–79
90 8.24 54 47 72.3 57.4 59.7 70.5
57–84 43–71 46–72 55–83
Table 4 Sensitivity, specificity, positive and  negative predictive values of  blood sucrose for  diagnosis of  CSL in  horses 
after administration of 1 g/kg of sucrose via nasogastric intubation
CSL clinically significant lesions, Se sensitivity, Sp specificity, NPV negative predictive value, PPV positive predictive value, 95% CI 95% confidence intervals
Time of sampling (min) Cut‑off (µmol/l) Disease present Disease absent Sp (%) Se (%) NPV (%) PPV (%)
95% CI 95% CI 95% CI 95% CI
45 4.61 59 42 50.0 74.6 58.3 67.7
34–66 62–85 41–75 55–79
90 5.87 59 42 52.4 76.3 61.1 69.2
36–68 63–86 44–77 57–80
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(4) clinically significant gastric lesions, perfect agreement 
between-observers within the 101 sets of observations 
was achieved on average, in 83% (K =  0.50; P < 0.0001; 
95% CI 0.24–0.76); 78% (K  =  0.57; P  <  0.0001; 95% CI 
0.39–0.75); 74% (K = 0.65; P < 0.0001; 95% CI 0.53–0.77); 
and 75% (K = 0.62; P < 0.0001; 95% CI 0.48–0.75) of the 
cases respectively.
Discussion
The objective of this study was to validate the sucrose 
blood test as a screening test for EGUS in adult horses 
by determining its performance characteristics in a large 
group of horses with and without naturally occurring 
gastric disease. ROC curve analysis was used to visually 
demonstrate the cut-off dependency of the test across a 
range of sucrose concentrations and to provide an esti-
mate of the overall diagnostic accuracy of the test that 
is independent of specific cut-off values or prevalence 
of gastric lesions in the study population. For this study, 
ROC curves of true positive rates (Se) against false posi-
tive rates (1-Sp) were plotted using blood sucrose con-
centrations from normal horses, and horses with GL, 
GDL, SQL and CSL at 45 and 90  min after administra-
tion of sucrose (Figs. 1, 2). The AUC’s in each plot rep-
resents a summary of the overall diagnostic accuracy of 
the test by combining accuracy over a range of cut-offs, 
with a value approaching 1.0 indicating perfect dis-
crimination and 0.5 representing zero discrimination. 
Using an arbitrary guideline, the AUC can be used to 
distinguish between a non-informative (AUC  =  0.5); 
less accurate (0.5  <  AUC  ≤  0.7); moderately accurate 
(0.7 < AUC ≤ 0.9); highly accurate (0.9 < AUC < 1); and 
perfect test (AUC = 1) [43]. Depending upon the lesion 
type and time of sampling, the AUC for the blood sucrose 
test ranged from 0.51 to 0.68, indicating that blood 
sucrose concentration is poor at discriminating between 
normal horses and horses with EGUS and is therefore not 
considered to be a very accurate test.
Because the AUC summarizes the ROC curve as a 
whole, and therefore attributes the same weighting to 
both relevant and irrelevant parts of the curve [44], cut-
off values were inserted on the continuous scale of test 
results that allowed calculation of Se and Sp for horses 
with GL, GDL, SQL and CSL at each time point. Using 
the selected cut-offs, the Se and Sp of the blood sucrose 
test for detecting the presence or absence of EGUS was 
low (Tables  1, 2, 3, 4), confirming the poor diagnostic 
accuracy of the test in this study population.
It is not immediately evident why the sucrose blood test 
has a poor diagnostic accuracy in adult horses despite 
previous literature to suggest otherwise [21–23]. In this 
study, there was a predominance of glandular lesions 
(70%) whereas in previous studies, sucrose permeability 
was assessed primarily on horses with squamous lesions; 
and it may be that there are fundamental differences in 
the permeability of the sucrose molecule between the 
glandular and squamous epithelium. It has been found 
that gap junctional intercellular communication (GJIC) 
plays an important role in the gastric mucosal defense 
system, and loss of GJIC is associated with ulcer forma-
tion. A recent study demonstrated the presence of spe-
cific gap junctions in the glandular mucosa of the equine 
stomach, however these gap junctions were absent in the 
squamous mucosa of the stomach [45]. This suggests that 
there are significant differences in the permeation path-
way of the glandular vs. the squamous epithelium which 
may explain (in part) why in this study population, with a 
predominace of glandular ulcers, the sucrose blood test 
had a poorer diagnostic accuracy than expected. Fur-
thermore, glandular lesions are often smaller in cross-
sectional area and are usually not ulcerative per se, but 
rather erosive or may even consist of intact mucosa with 
hyperemia [1]. In such cases, it is possible that sucrose 
is less likely to permeate in quantities large enough to 
appreciate differences between affected and unaffected 
horses, although this has yet to be substantiated.
The authors do recognize however, that the sensitivity 
and specificity for squamous lesions was also poor, albeit 
less so than for glandular ulcers. Another factor to con-
sider therefore, is the fact that in this particular study, 
very few of the squamous lesions were extensive or dem-
onstrated areas of apparent deep ulceration characteristic 
of EGUS severity score ≥3 [1]. It is therefore possible that 
in such cases, the total surface area for sucrose permea-
tion was too small to differentiate between affected and 
unaffected horses. Based on this premise, re-analysis of 
the data using a scoring system that takes into account 
not only the severity of the lesion, but also the number of 
lesions should be considered [46].
Alternatively, the validity of the gold standard itself 
can be questioned. It may be that the sucrose test is too 
sensitive and may detect slight and clinically insignifi-
cant mucosal damage that cannot be seen on endos-
copy, thus limiting its use in clinical decision-making 
regarding gastric ulceration [33]. We postulate that 
sucrose permeability is in fact an accurate represen-
tation of the true mucosal integrity of the stomach 
based on a number of previous publications document-
ing its effectiveness in both humans and other species 
[35, 36, 38, 47]; and that assessment via endoscopy is 
under- or overestimating the severity or depth of gas-
tric lesions. This is based on the fact that assessment 
of lesion severity (and even the presence or absence of 
lesions) using gastroscopy is subjective, and agreement 
between observers for endoscopic diagnosis is notori-
ously poor, particularly if they are inexperienced [48, 
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49]. Furthermore, it has been demonstrated that there 
is a poor correlation between endoscopic assessment 
of gastric ulcers ante mortem and histological appear-
ance at necropsy [46, 50]. Because of these limitations, 
an attempt was made in this study to determine if the 
gold standard was reproducible between-observers. All 
assessments made by the observer were compared with 
assessments made by two other board certified intern-
ists that have experience with gastroscopy, and the level 
of agreement for each outcome was determined. Agree-
ment was moderate [51], but still unacceptably low, and 
it is possible that in the hands of different observers, 
the diagnostic accuracy of the test will vary. Consider-
ing these limitations, it is the authors’ opinion that his-
topathology rather than endoscopy should be utilized 
as a gold standard for comparison in future gastric 
permeability studies. Alternatively, Bayesian statistical 
approaches that are used for evaluation of diagnostic 
tests in the absence of a gold standard test should be 
considered [52].
The choice to include the severity of gastric ulceration 
in the study was based on the premise that the sucrose 
blood test would be able to differentiate between severe 
and less severe lesions, enabling practitioners to select 
cases for treatment based upon the outcome of the test. 
Unfortunately there are no grading systems that can be 
used interchangeably for horses with both ESGD and 
EGGD [53], and so the authors elected to use the concept 
of a ‘clinically significant gastric lesion’ as a proxy indi-
cator of ulcer severity, where clinically significant lesions 
were defined as lesions that the observer would consider 
severe enough to warrant treatment if seen in a clinical 
case. While the authors recognize that this is not a per-
fect solution, as clinicians will usually use both gastro-
scopic appearance of lesions in combination with the 
clinical history to determine clinically significance, the 
authors believe that this proxy is the best possible com-
promise. While a scoring system (e.g. EGUS 0-4) would 
have been more objective, the fact that it cannot be used 
for EGGD makes it impossible to be used in this study. In 
future, assessment of both clinical and endoscopic out-
comes when determining the diagnostic accuracy of the 
sucrose test is recommended.
When conducting a validation study to determine 
the diagnostic accuracy of a test, it is essential that the 
study include an appropriate spectrum of subjects which 
is representative of the population for which the test is 
intended. We aimed to determine the diagnostic accu-
racy of the sucrose blood test as a screening test for 
EGUS in adult horses and therefore we selected horses 
used for a wide spectrum of activities, ranging from dres-
sage to racing. Eighty four percent of the horses in the 
study population had gastric lesions, which is similar to 
previously reported prevalence data for this geographical 
region [14]. Unfortunately, there was a limited spectrum 
of disease in the study population, with a predomi-
nance of small single lesions and a noticeable absence of 
extensive lesions with areas of apparent deep ulceration. 
As discussed earlier, this has the potential to skew the 
results by virtue of the fact that permeability of sucrose is 
directly proportional to the surface area of the damaged 
gastric mucosa available for permeation. An additional 
limitation of the study was the fact that that a proportion 
of the horses in this study (58/101) showed no clinical 
signs of gastric ulceration at the time of sucrose test-
ing. There is currently little evidence to suggest a direct 
cause-and-effect relationship between clinical signs of 
EGUS and the presence, severity or location of gastric 
ulcers in adult horses [1] and, therefore, it is possible 
that the diagnostic accuracy of the sucrose test would be 
improved when testing a population of horses that were 
all demonstrating clinical signs at the time of gastroscopy.
Conclusions
Blood sucrose was neither a sensitive nor specific test for 
detecting EGUS in this population of adult horses with 
naturally occurring disease. This study included both 
horses with and without clinical signs of gastric ulcera-
tion. Further studies aimed at evaluating the perfor-
mance characteristics of the test in a selected population 
of horses demonstrating clinical signs consistent with 
EGUS may be warranted. Given the limitations of endos-
copy, due consideration should also be given to alterna-
tive methods for comparison of blood sucrose with a gold 
standard (Additional file 1).
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